Katayoun A. Jessen
- Co-authors
- Michael SatreKurt R. GehlsenSergei MaliartchoukBen TsengHan‐Zhong ZhangShailaja KasibhatlaLing QiuNicole M. English
- Topics
- Chronic Lymphocytic Leukemia Research (3 papers)Chronic Myeloid Leukemia Treatments (3 papers)PI3K/AKT/mTOR signaling in cancer (3 papers)
- Cited by
- HematologyGeneticsOrganic Chemistry
- Partner nations
- United StatesSwitzerland
In The Last Decade
Katayoun A. Jessen
18 papers receiving 435 citations
Peers
Comparison fields: 5 of 67
- Molecular Biology 216
- Organic Chemistry 129
- Plant Science 104
- Oncology 82
- Hematology 73
Countries citing papers authored by Katayoun A. Jessen
This map shows the geographic impact of Katayoun A. Jessen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katayoun A. Jessen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katayoun A. Jessen more than expected).
Fields of papers citing papers by Katayoun A. Jessen
This network shows the impact of papers produced by Katayoun A. Jessen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katayoun A. Jessen. The network helps show where Katayoun A. Jessen may publish in the future.
Co-authorship network of co-authors of Katayoun A. Jessen
This figure shows the co-authorship network connecting the top 25 collaborators of Katayoun A. Jessen. A scholar is included among the top collaborators of Katayoun A. Jessen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katayoun A. Jessen. Katayoun A. Jessen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 20 | |
| 6 | 59 | |
| 7 | In vitro and in vivo antitumor activities of SGX523, a novel MET inhibitor | 3 |
| 8 | Selective inhibition of MET protein receptor tyrosine kinase by SGX523 | 6 |
| 9 | 3 | |
| 10 | In vitro combination studies of Troxacitabine (Troxatyl™, SGX-145) against human tumor cell lines. | 1 |
| 11 | 9 | |
| 12 | 67 | |
| 13 | 193 | |
| 14 | 44 | |
| 15 | 8 | |
| 16 | 17 | |
| 17 | 14 | |
| 18 | 9 |
About Katayoun A. Jessen
Katayoun A. Jessen is a scholar working on Hematology, Genetics and Hepatology, having authored 18 papers that have together received 465 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Hematology (73 citations), Genetics (62 citations) and Organic Chemistry (129 citations). Katayoun A. Jessen has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Michael Satre, Kurt R. Gehlsen, Sergei Maliartchouk, Ben Tseng, Han‐Zhong Zhang, Shailaja Kasibhatla, Ling Qiu, Nicole M. English, John Drewe and Sui Xiong Cai. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.